These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17093258)

  • 1. A new approach to drug development.
    Guda HE
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17093258
    [No Abstract]   [Full Text] [Related]  

  • 2. A new approach to drug development.
    Frangioni JV
    N Engl J Med; 2006 Nov; 355(19):2046; author reply 2046. PubMed ID: 17099947
    [No Abstract]   [Full Text] [Related]  

  • 3. A new approach to drug development.
    Mayer D
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099949
    [No Abstract]   [Full Text] [Related]  

  • 4. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

  • 5. Key factors in the rising cost of new drug discovery and development.
    Dickson M; Gagnon JP
    Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug evaluation and approval process in the European Union.
    San Miguel MT; Vargas E
    Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405
    [No Abstract]   [Full Text] [Related]  

  • 7. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
    Nesi T
    US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444
    [No Abstract]   [Full Text] [Related]  

  • 8. Industry looks to buck bias in emerging 'adaptive' designs.
    Torres C
    Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301
    [No Abstract]   [Full Text] [Related]  

  • 9. Orphan drug development for the treatment of rare chronic diseases.
    Moore ES
    Tex Hosp; 1988 Jul; 44(2):20-1. PubMed ID: 10288218
    [No Abstract]   [Full Text] [Related]  

  • 10. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 11. Canadian and US drug approval times and safety considerations.
    Rawson NS; Kaitin KI
    Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose of reality for rational therapies.
    Nat Biotechnol; 2005 Mar; 23(3):267. PubMed ID: 15765066
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug development for neglected diseases - the trouble with FDA review vouchers.
    Kesselheim AS
    N Engl J Med; 2008 Nov; 359(19):1981-3. PubMed ID: 18987367
    [No Abstract]   [Full Text] [Related]  

  • 15. Takings issues in the approval of generic biologics.
    Yoo JC
    Food Drug Law J; 2005; 60(1):33-43. PubMed ID: 15940853
    [No Abstract]   [Full Text] [Related]  

  • 16. The needs of the few.
    Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796
    [No Abstract]   [Full Text] [Related]  

  • 17. Viewpoint: Sir Richard Sykes, DSc, FRS, FMedSci. Interview by Ingrid Torjesen, BSc.
    Sykes R
    Circulation; 2006 Jun; 113(22):f85-6. PubMed ID: 16754809
    [No Abstract]   [Full Text] [Related]  

  • 18. [For new antimalarial drugs: the methods of fundamental research].
    Ambroise-Thomas P
    Med Trop (Mars); 1995; 55(4 Suppl):23-6. PubMed ID: 8649261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug safety special: the safety catch.
    Wadman M
    Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug review "behind the curtain": a response to Professor Struve.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.